| Financial Year |
March 31 2023 |
| Monetary Funds |
5,416,831,693.41 |
| Held-for-trading Financial Assets |
771,057,398.22 |
| Notes Receivable |
921,544,944.94 |
| Accounts Receivable |
687,466,616.89 |
| Advances to Suppliers |
181,579,649.50 |
| Other Receivables |
135,267,194.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,177,838,039.79 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,434,247.75 |
| Total Current Assets |
10,858,870,438.76 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
7,056,764,912.68 |
| Investment Properties |
-- |
| Fixed Assetes |
2,533,364,231.07 |
| Under-construction Projects |
355,793,145.93 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
429,611,418.38 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,447,146.57 |
| Deferred Income Tax Assets |
80,303,083.04 |
| Other Non-Current Assets |
95,321,367.45 |
| Sub-Total of Non-Current Assets |
10,896,591,053.82 |
| Total Assets |
21,755,461,492.58 |
| Short-Term Loans |
442,470,641.30 |
| Trading Financial liabilities |
-- |
| Notes Payable |
542,127,230.37 |
| Accounts Payable |
511,678,920.95 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
44,118,942.29 |
| Taxes Payable |
42,428,125.28 |
| Interest Payable |
219,899.12 |
| Dividend Payable |
2,139,998.15 |
| Other payables |
187,821,282.22 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,920,420.79 |
| Other Current Liabilities |
310,356,749.28 |
| Sub-Total of Current Liabilities |
2,351,752,415.80 |
| Long-term Loans |
642,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
27,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
61,023,864.87 |
| Other Non-Current Liabilities |
110,485,240.27 |
| Sub-Total of Non-Current Liabilities |
1,142,878,861.47 |
| Total Liabilities |
3,494,631,277.27 |
| Paid-In Capital(Or Share Stock) |
4,025,970,368.00 |
| Capital Surplus |
1,974,527,557.00 |
| Surplus Reserve |
1,413,211,549.29 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
9,677,715,885.67 |
| Minority Stockholder's Interest |
1,110,703,492.64 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
17,150,126,722.67 |
| Owner's Equity（Stockholder's Equity） |
18,260,830,215.31 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
21,755,461,492.58 |
